Aspirin resistance in off-pump coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 1, 2012, Pages 108-112

  Wang, Zanxin ^a   Gao, Fei ^a   Men, Jianlong ^a   Ren, Jing ^a   Modi, Paul ^b   Wei, Minxin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Aspirin resistance; Coronary artery bypass grafting; Platelet aggregation; Thromboxane

Indexed keywords

11 DEHYDRO THROMBOXANE B2; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOXANE B2; UNCLASSIFIED DRUG; 11-DEHYDRO-THROMBOXANE B2; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; DRUG DERIVATIVE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; URINE LEVEL; AGED; CASE CONTROL STUDY; DRUG ADMINISTRATION; DRUG EFFECT; DRUG RESISTANCE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; THROMBOCYTE COUNT; THROMBOSIS; URINE;

AGED; ASPIRIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS, OFF-PUMP; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; THROMBOSIS; THROMBOXANE B2;

EID: 84860333698     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.04.021     Document Type: Article

References (25)

1. Karzai W, Priebe HJ. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2003;348:1057-9.
2. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003;108:542-7.
3. Poston RS, Gu J, White C, Jeudy J, Nie L, Brown J, Gammie J, Pierson RN, Romar L, Griffith BP. Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.Transfusion 2008;48:39S-46S.
4. Payne DA, Jones CI, Hayes PD, Webster SE, Naylor AR, Goodall AH. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?. Thromb Haemost 2004;92:89-96.
5. Ballotta A, Saleh HZ, El Baghdady HW, Gomaa M, Belloli F, Kandil H, Balbaa Y, Bettini F, Bossone E, Menicanti L, Frigiola A, Bellucci C,Mehta RH. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;134:132-8.
6. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D. Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group. On-pump versus off-pump coronaryartery bypass surgery. N Engl J Med 2009;361:1827-37.
7. Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995;11:221-7.
8. Thomas GN, Martinez EC, Woitek F, Emmert MY, Sakaguchi H, Muecke S, Lee CN, Kofidis T. Off-pump coronary bypass grafting is safe and efficient in patients with left main disease and higher EuroScore. Eur J Cardiothorac Surg 2009;3:616-20.
9. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-8.
10. Cattaneo M. Laboratory detection of 'aspirin resistance': what test should we use (if any)?. Eur Heart J 2007;28:1673-5.
11. Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN 3rd, Griffith BP. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006;131:122-30.
12. Bednar F, Osmancik P, Hlavicka J, Jedlickova V, Paluch Z, Vanek T. Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery. J Thromb Thrombolysis 2009;27:394-9.
13. Kempfert J, Anger K, Rastan A, Krabbes S, Lehmann S, Garbade J, Sauer M, Walther T, Dhein S, Mohr FW. Postoperative development of aspirin resistance following coronary artery bypass. Eur J Clin Invest 2009;39: 769-74.
14. Nishiyama K, Horiguchi M, Shizuta S, Doi T, Ehara N, Tanuguchi R, Haruna Y, Nakagawa Y, Furukawa Y, Fukushima M, Kita T, Kimura T Temporal pattern of strokes after on-pump and off-pump coronary artery bypass graft surgery. Ann Thorac Surg 2009;87:1839-44.
15. Zimmermann N, Gams E, Hohlfeld T. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur J Cardiothorac Surg 2008;34:93-108.
16. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?. Eur J Cardiothorac Surg 2005;27:606-10.
17. Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Vaidya D, Moy TF, Fallin MD, Wilson AF, Bray PF, Becker LC, Becker DM. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation 2007;115:2490-6.
18. Golaski J, Chlopicki S, Golaski R, Gresner P, Iwaszkiewicz A, Watala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy. Ther Drug Monit 2005;27:484-90.
19. Zimmermann N, Kurt M, Winter J, Gams E, Wenzel F, Hohlfeld T. Detection and duration of aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008;135:947-8.
20. Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007;115:2196-207.
21. Sanioglu S, Tetik S, Sokullu O, Deniz H, Aydemir N, Yilmaz M, Arslan IY, Bilgen F. Aspirin resistance after CABG. Thorac Cardiovasc Surg 2009;57: 281-5.
22. Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 2006;29:190-5.
23. Gao C, Ren C, Li D, Li L. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg 2009;88:59-62.
24. Kulik A, Le May MR, Voisine P, Tardif JC, Delarochelliere R, Naidoo S, Wells GA, Mesana TG, Ruel M. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial. Circulation 2010;122: 2680-7.
25. Brambilla M, Parolari A, Camera M, Colli S, Eligini S, Centenaro C, Anselmo A, Alamanni F, Tremoli E. Effect of two doses of aspirin onthromboxane biosynthesis and platelet function in patients undergoing coronary surgery. Thromb Haemost 2010;103:516-24.